This tiny brain implant could treat depression at home
Motif Neurotech has developed a tiny brain implant aimed at treating treatment-resistant depression. The FDA has approved human trials for this device, which is designed to stimulate brain activity in patients with major depressive disorder. The implant delivers electrical pulses to a specific area of the brain to help alleviate symptoms of depression.
- ▪Nearly 3 million Americans suffer from treatment-resistant depression.
- ▪The FDA has greenlighted a human trial for a new brain implant.
- ▪The device targets the brain region responsible for high-level thinking that is often inactive in depressed individuals.
Opening excerpt (first ~120 words) tap to expand
Nearly 3 million Americans suffer from treatment-resistant depression, meaning antidepressants simply don’t work for them. Motif Neurotech wants to change that with a tiny brain implant, and the FDA has just greenlighted a human trial to test it. As reported by Wired, the Houston-based startup has developed a tiny device that sits in the skull, just above the brain’s protective membrane. It targets the part of the brain responsible for high-level thinking that tends to go quiet in people with major depressive disorder. The implant delivers precise electrical pulses to wake that network back up.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Digital Trends.